Signal2026-07-20
ClinicalTrials.gov

[PHASE1] A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma

Part of

Molecular Profiling In Endocrine Neoplasms

Open primary sourceRead on Substack